Macquarie Group’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-204,803
| Closed | -$4.48M | – | 1648 |
|
|
2025
Q1 | $4.48M | Buy |
204,803
+3,736
| +2% | +$81.7K | 0.01% | 1007 |
|
|
2024
Q4 | $6.42M | Buy |
201,067
+17,778
| +10% | +$567K | 0.01% | 892 |
|
|
2024
Q3 | $5.29M | Sell |
183,289
-1,642
| -0.9% | -$47.4K | 0.01% | 953 |
|
|
2024
Q2 | $7.09M | Sell |
184,931
-36,723
| -17% | -$1.41M | 0.01% | 892 |
|
|
2024
Q1 | $13M | Sell |
221,654
-361,775
| -62% | -$21.3M | 0.01% | 766 |
|
|
2023
Q4 | $34.9M | Sell |
583,429
-493,119
| -46% | -$29.5M | 0.04% | 540 |
|
|
2023
Q3 | $41M | Buy |
1,076,548
+301,068
| +39% | +$11.5M | 0.05% | 461 |
|
|
2023
Q2 | $70.6M | Sell |
775,480
-635,999
| -45% | -$57.9M | 0.08% | 328 |
|
|
2023
Q1 | $93.1M | Sell |
1,411,479
-50,163
| -3% | -$3.31M | 0.11% | 251 |
|
|
2022
Q4 | $75.6M | Buy |
1,461,642
+40,107
| +3% | +$2.07M | 0.09% | 312 |
|
|
2022
Q3 | $97.2M | Buy |
1,421,535
+38,028
| +3% | +$2.6M | 0.12% | 232 |
|
|
2022
Q2 | $62.6M | Buy |
1,383,507
+61,949
| +5% | +$2.8M | 0.07% | 378 |
|
|
2022
Q1 | $67.1K | Buy |
1,321,558
+29,775
| +2% | +$1.51K | 0.05% | 422 |
|
|
2021
Q4 | $61.1M | Buy |
1,291,783
+171,693
| +15% | +$8.12M | 0.05% | 450 |
|
|
2021
Q3 | $36.9M | Buy |
1,120,090
+574,416
| +105% | +$18.9M | 0.03% | 597 |
|
|
2021
Q2 | $34.5M | Buy |
545,674
+543,529
| +25,339% | +$34.4M | 0.03% | 646 |
|
|
2021
Q1 | $92K | Sell |
2,145
-717
| -25% | -$30.8K | ﹤0.01% | 1933 |
|
|
2020
Q4 | $164K | Hold |
2,862
| – | – | ﹤0.01% | 1731 |
|
|
2020
Q3 | $86K | Hold |
2,862
| – | – | ﹤0.01% | 1822 |
|
|
2020
Q2 | $93K | Buy |
+2,862
| New | +$93K | ﹤0.01% | 1770 |
|